APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Galectin 3

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Galectin 3 Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchGalectin 3 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Galectin 3 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Galectin 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galectin 3 Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Galectin 3 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Galectin 3 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Galectin 3 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Galectin 3 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Galectin 3 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Galectin 3 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Galectin 3 include MandalMed Inc, iTeos Therapeutics SA, GlycoMimetics Inc, Galectin Therapeutics Inc, Bristol-Myers Squibb Company and Angion Biomedica Corp, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Galectin 3, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Galectin 3, also provides the sales of main regions and countries. Of the upcoming market potential for Galectin 3, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Galectin 3 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Galectin 3 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Galectin 3 sales, projected growth trends, production technology, application and end-user industry.

Galectin 3 Segment by Company

MandalMed Inc

iTeos Therapeutics SA

GlycoMimetics Inc

Galectin Therapeutics Inc

Bristol-Myers Squibb Company

Angion Biomedica Corp

Galectin 3 Segment by Type

KTI

GRMD-03

GAL-300

ANG-4021

Others

Galectin 3 Segment by Application

Metastatic Melanoma

Portal Hypertension

Liver Cirrhosis

Others

Galectin 3 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galectin 3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galectin 3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galectin 3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Galectin 3 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Galectin 3 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Galectin 3 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Galectin 3 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. KTI Major Manufacturers Table 3. GRMD-03 Major Manufacturers Table 4. GAL-300 Major Manufacturers Table 5. ANG-4021 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Galectin 3 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Metastatic Melanoma Major Manufacturers Table 9. Portal Hypertension Major Manufacturers Table 10. Liver Cirrhosis Major Manufacturers Table 11. Others Major Manufacturers Table 12. Galectin 3 Industry Trends Table 13. Galectin 3 Industry Drivers Table 14. Galectin 3 Industry Opportunities and Challenges Table 15. Galectin 3 Industry Restraints Table 16. Global Galectin 3 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Galectin 3 Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Galectin 3 Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Galectin 3 Revenue Market Share by Region (2021-2026) Table 20. Global Galectin 3 Revenue Market Share by Region (2027-2032) Table 21. Global Galectin 3 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Galectin 3 Sales by Region (2021-2026) & (k units) Table 23. Global Galectin 3 Sales by Region (2027-2032) & (k units) Table 24. Global Galectin 3 Sales Market Share by Region (2021-2026) Table 25. Global Galectin 3 Sales Market Share by Region (2027-2032) Table 26. Global Galectin 3 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Galectin 3 Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Galectin 3 Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Galectin 3 Sales Market Share by Manufacturers (2021-2026) Table 30. Global Galectin 3 Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Galectin 3 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Galectin 3 Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Galectin 3 Manufacturers, Product Type & Application Table 34. Global Galectin 3 Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Galectin 3 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Galectin 3 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Galectin 3 Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Galectin 3 Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Galectin 3 Revenue Market Share by Type (2021-2026) Table 41. Global Galectin 3 Revenue Market Share by Type (2027-2032) Table 42. Global Galectin 3 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Galectin 3 Sales by Type (2021-2026) & (k units) Table 44. Global Galectin 3 Sales by Type (2027-2032) & (k units) Table 45. Global Galectin 3 Sales Market Share by Type (2021-2026) Table 46. Global Galectin 3 Sales Market Share by Type (2027-2032) Table 47. Global Galectin 3 Price by Type (2021-2026) & (US$/unit) Table 48. Global Galectin 3 Price by Type (2027-2032) & (US$/unit) Table 49. Global Galectin 3 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Galectin 3 Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Galectin 3 Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Galectin 3 Revenue Market Share by Application (2021-2026) Table 53. Global Galectin 3 Revenue Market Share by Application (2027-2032) Table 54. Global Galectin 3 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Galectin 3 Sales by Application (2021-2026) & (k units) Table 56. Global Galectin 3 Sales by Application (2027-2032) & (k units) Table 57. Global Galectin 3 Sales Market Share by Application (2021-2026) Table 58. Global Galectin 3 Sales Market Share by Application (2027-2032) Table 59. Global Galectin 3 Price by Application (2021-2026) & (US$/unit) Table 60. Global Galectin 3 Price by Application (2027-2032) & (US$/unit) Table 61. MandalMed Inc Company Information Table 62. MandalMed Inc Business Overview Table 63. MandalMed Inc Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. MandalMed Inc Galectin 3 Product Portfolio Table 65. MandalMed Inc Recent Development Table 66. iTeos Therapeutics SA Company Information Table 67. iTeos Therapeutics SA Business Overview Table 68. iTeos Therapeutics SA Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. iTeos Therapeutics SA Galectin 3 Product Portfolio Table 70. iTeos Therapeutics SA Recent Development Table 71. GlycoMimetics Inc Company Information Table 72. GlycoMimetics Inc Business Overview Table 73. GlycoMimetics Inc Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. GlycoMimetics Inc Galectin 3 Product Portfolio Table 75. GlycoMimetics Inc Recent Development Table 76. Galectin Therapeutics Inc Company Information Table 77. Galectin Therapeutics Inc Business Overview Table 78. Galectin Therapeutics Inc Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Galectin Therapeutics Inc Galectin 3 Product Portfolio Table 80. Galectin Therapeutics Inc Recent Development Table 81. Bristol-Myers Squibb Company Company Information Table 82. Bristol-Myers Squibb Company Business Overview Table 83. Bristol-Myers Squibb Company Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Bristol-Myers Squibb Company Galectin 3 Product Portfolio Table 85. Bristol-Myers Squibb Company Recent Development Table 86. Angion Biomedica Corp Company Information Table 87. Angion Biomedica Corp Business Overview Table 88. Angion Biomedica Corp Galectin 3 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Angion Biomedica Corp Galectin 3 Product Portfolio Table 90. Angion Biomedica Corp Recent Development Table 91. North America Galectin 3 Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Galectin 3 Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Galectin 3 Sales by Type (2021-2026) & (k units) Table 94. North America Galectin 3 Sales by Type (2027-2032) & (k units) Table 95. North America Galectin 3 Sales Price by Type (2021-2026) & (US$/unit) Table 96. North America Galectin 3 Sales Price by Type (2027-2032) & (US$/unit) Table 97. North America Galectin 3 Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Galectin 3 Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Galectin 3 Sales by Application (2021-2026) & (k units) Table 100. North America Galectin 3 Sales by Application (2027-2032) & (k units) Table 101. North America Galectin 3 Sales Price by Application (2021-2026) & (US$/unit) Table 102. North America Galectin 3 Sales Price by Application (2027-2032) & (US$/unit) Table 103. North America Galectin 3 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Galectin 3 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America Galectin 3 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America Galectin 3 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 107. North America Galectin 3 Sales by Country (2021-2026) & (k units) Table 108. North America Galectin 3 Sales by Country (2027-2032) & (k units) Table 109. North America Galectin 3 Sales Price by Country (2021-2026) & (US$/unit) Table 110. North America Galectin 3 Sales Price by Country (2027-2032) & (US$/unit) Table 111. United States Galectin 3 Revenue (2021-2032) & (US$ Million) Table 112. Canada Galectin 3 Revenue (2021-2032) & (US$ Million) Table 113. Mexico Galectin 3 Revenue (2021-2032) & (US$ Million) Table 114. Europe Galectin 3 Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Galectin 3 Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Galectin 3 Sales by Type (2021-2026) & (k units) Table 117. Europe Galectin 3 Sales by Type (2027-2032) & (k units) Table 118. Europe Galectin 3 Sales Price by Type (2021-2026) & (US$/unit) Table 119. Europe Galectin 3 Sales Price by Type (2027-2032) & (US$/unit) Table 120. Europe Galectin 3 Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Galectin 3 Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Galectin 3 Sales by Application (2021-2026) & (k units) Table 123. Europe Galectin 3 Sales by Application (2027-2032) & (k units) Table 124. Europe Galectin 3 Sales Price by Application (2021-2026) & (US$/unit) Table 125. Europe Galectin 3 Sales Price by Application (2027-2032) & (US$/unit) Table 126. Europe Galectin 3 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Galectin 3 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe Galectin 3 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe Galectin 3 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 130. Europe Galectin 3 Sales by Country (2021-2026) & (k units) Table 131. Europe Galectin 3 Sales by Country (2027-2032) & (k units) Table 132. Europe Galectin 3 Sales Price by Country (2021-2026) & (US$/unit) Table 133. Europe Galectin 3 Sales Price by Country (2027-2032) & (US$/unit) Table 134. Germany Galectin 3 Revenue (2021-2032) & (US$ Million) Table 135. France Galectin 3 Revenue (2021-2032) & (US$ Million) Table 136. U.K. Galectin 3 Revenue (2021-2032) & (US$ Million) Table 137. Italy Galectin 3 Revenue (2021-2032) & (US$ Million) Table 138. Russia Galectin 3 Revenue (2021-2032) & (US$ Million) Table 139. Spain Galectin 3 Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Galectin 3 Revenue (2021-2032) & (US$ Million) Table 141. Switzerland Galectin 3 Revenue (2021-2032) & (US$ Million) Table 142. Sweden Galectin 3 Revenue (2021-2032) & (US$ Million) Table 143. Poland Galectin 3 Revenue (2021-2032) & (US$ Million) Table 144. China Galectin 3 Revenue by Type (2021-2026) & (US$ Million) Table 145. China Galectin 3 Revenue by Type (2027-2032) & (US$ Million) Table 146. China Galectin 3 Sales by Type (2021-2026) & (k units) Table 147. China Galectin 3 Sales by Type (2027-2032) & (k units) Table 148. China Galectin 3 Sales Price by Type (2021-2026) & (US$/unit) Table 149. China Galectin 3 Sales Price by Type (2027-2032) & (US$/unit) Table 150. China Galectin 3 Revenue by Application (2021-2026) & (US$ Million) Table 151. China Galectin 3 Revenue by Application (2027-2032) & (US$ Million) Table 152. China Galectin 3 Sales by Application (2021-2026) & (k units) Table 153. China Galectin 3 Sales by Application (2027-2032) & (k units) Table 154. China Galectin 3 Sales Price by Application (2021-2026) & (US$/unit) Table 155. China Galectin 3 Sales Price by Application (2027-2032) & (US$/unit) Table 156. Asia Galectin 3 Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Galectin 3 Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Galectin 3 Sales by Type (2021-2026) & (k units) Table 159. Asia Galectin 3 Sales by Type (2027-2032) & (k units) Table 160. Asia Galectin 3 Sales Price by Type (2021-2026) & (US$/unit) Table 161. Asia Galectin 3 Sales Price by Type (2027-2032) & (US$/unit) Table 162. Asia Galectin 3 Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Galectin 3 Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Galectin 3 Sales by Application (2021-2026) & (k units) Table 165. Asia Galectin 3 Sales by Application (2027-2032) & (k units) Table 166. Asia Galectin 3 Sales Price by Application (2021-2026) & (US$/unit) Table 167. Asia Galectin 3 Sales Price by Application (2027-2032) & (US$/unit) Table 168. Asia Galectin 3 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Galectin 3 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Galectin 3 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Galectin 3 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 172. Asia Galectin 3 Sales by Country (2021-2026) & (k units) Table 173. Asia Galectin 3 Sales by Country (2027-2032) & (k units) Table 174. Asia Galectin 3 Sales Price by Country (2021-2026) & (US$/unit) Table 175. Asia Galectin 3 Sales Price by Country (2027-2032) & (US$/unit) Table 176. Japan Galectin 3 Revenue (2021-2032) & (US$ Million) Table 177. South Korea Galectin 3 Revenue (2021-2032) & (US$ Million) Table 178. India Galectin 3 Revenue (2021-2032) & (US$ Million) Table 179. Australia Galectin 3 Revenue (2021-2032) & (US$ Million) Table 180. Taiwan Galectin 3 Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Galectin 3 Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Galectin 3 Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Galectin 3 Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Galectin 3 Sales by Type (2021-2026) & (k units) Table 185. SAMEA Galectin 3 Sales by Type (2027-2032) & (k units) Table 186. SAMEA Galectin 3 Sales Price by Type (2021-2026) & (US$/unit) Table 187. SAMEA Galectin 3 Sales Price by Type (2027-2032) & (US$/unit) Table 188. SAMEA Galectin 3 Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Galectin 3 Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Galectin 3 Sales by Application (2021-2026) & (k units) Table 191. SAMEA Galectin 3 Sales by Application (2027-2032) & (k units) Table 192. SAMEA Galectin 3 Sales Price by Application (2021-2026) & (US$/unit) Table 193. SAMEA Galectin 3 Sales Price by Application (2027-2032) & (US$/unit) Table 194. SAMEA Galectin 3 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Galectin 3 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Galectin 3 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Galectin 3 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 198. SAMEA Galectin 3 Sales by Country (2021-2026) & (k units) Table 199. SAMEA Galectin 3 Sales by Country (2027-2032) & (k units) Table 200. SAMEA Galectin 3 Sales Price by Country (2021-2026) & (US$/unit) Table 201. SAMEA Galectin 3 Sales Price by Country (2027-2032) & (US$/unit) Table 202. Brazil Galectin 3 Revenue (2021-2032) & (US$ Million) Table 203. Argentina Galectin 3 Revenue (2021-2032) & (US$ Million) Table 204. Chile Galectin 3 Revenue (2021-2032) & (US$ Million) Table 205. Colombia Galectin 3 Revenue (2021-2032) & (US$ Million) Table 206. Peru Galectin 3 Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Galectin 3 Revenue (2021-2032) & (US$ Million) Table 208. Israel Galectin 3 Revenue (2021-2032) & (US$ Million) Table 209. UAE Galectin 3 Revenue (2021-2032) & (US$ Million) Table 210. Turkey Galectin 3 Revenue (2021-2032) & (US$ Million) Table 211. Iran Galectin 3 Revenue (2021-2032) & (US$ Million) Table 212. Egypt Galectin 3 Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Galectin 3 Distributors List Table 216. Galectin 3 Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Galectin 3 Image Figure 2. Global Galectin 3 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galectin 3 Market Size Share 2021 VS 2025 VS 2032 Figure 4. KTI Image Figure 5. GRMD-03 Image Figure 6. GAL-300 Image Figure 7. ANG-4021 Image Figure 8. Others Image Figure 9. Global Galectin 3 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Galectin 3 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Metastatic Melanoma Image Figure 12. Portal Hypertension Image Figure 13. Liver Cirrhosis Image Figure 14. Others Image Figure 15. Global Galectin 3 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Galectin 3 Revenue (2021-2032) & (US$ Million) Figure 17. Global Galectin 3 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Galectin 3 Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Galectin 3 Revenue Market Share by Region (2021-2032) Figure 20. Global Galectin 3 Sales (2021-2032) & (k units) Figure 21. Global Galectin 3 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Galectin 3 Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Galectin 3 Sales YoY (2021-2032) & (k units) Figure 24. Europe Galectin 3 Sales YoY (2021-2032) & (k units) Figure 25. China Galectin 3 Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Galectin 3 Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Galectin 3 Sales YoY (2021-2032) & (k units) Figure 28. Global Galectin 3 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Galectin 3 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Galectin 3 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Galectin 3 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Galectin 3 Revenue Market Share by Type (2021-2032) Figure 34. Global Galectin 3 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Galectin 3 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Galectin 3 Sales Market Share by Type (2021-2032) Figure 37. Global Galectin 3 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Galectin 3 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Galectin 3 Revenue Market Share by Application (2021-2032) Figure 40. Global Galectin 3 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Galectin 3 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Galectin 3 Sales Market Share by Application (2021-2032) Figure 43. North America Galectin 3 Revenue Share by Type (2021-2032) Figure 44. North America Galectin 3 Sales Share by Type (2021-2032) Figure 45. North America Galectin 3 Revenue Share by Application (2021-2032) Figure 46. North America Galectin 3 Sales Share by Application (2021-2032) Figure 47. North America Galectin 3 Revenue Share by Country (2021-2032) Figure 48. North America Galectin 3 Sales Share by Country (2021-2032) Figure 49. Europe Galectin 3 Revenue Share by Type (2021-2032) Figure 50. Europe Galectin 3 Sales Share by Type (2021-2032) Figure 51. Europe Galectin 3 Revenue Share by Application (2021-2032) Figure 52. Europe Galectin 3 Sales Share by Application (2021-2032) Figure 53. Europe Galectin 3 Revenue Share by Country (2021-2032) Figure 54. Europe Galectin 3 Sales Share by Country (2021-2032) Figure 55. China Galectin 3 Revenue Share by Type (2021-2032) Figure 56. China Galectin 3 Sales Share by Type (2021-2032) Figure 57. China Galectin 3 Revenue Share by Application (2021-2032) Figure 58. China Galectin 3 Sales Share by Application (2021-2032) Figure 59. Asia Galectin 3 Revenue Share by Type (2021-2032) Figure 60. Asia Galectin 3 Sales Share by Type (2021-2032) Figure 61. Asia Galectin 3 Revenue Share by Application (2021-2032) Figure 62. Asia Galectin 3 Sales Share by Application (2021-2032) Figure 63. Asia Galectin 3 Revenue Share by Country (2021-2032) Figure 64. Asia Galectin 3 Sales Share by Country (2021-2032) Figure 65. SAMEA Galectin 3 Revenue Share by Type (2021-2032) Figure 66. SAMEA Galectin 3 Sales Share by Type (2021-2032) Figure 67. SAMEA Galectin 3 Revenue Share by Application (2021-2032) Figure 68. SAMEA Galectin 3 Sales Share by Application (2021-2032) Figure 69. SAMEA Galectin 3 Revenue Share by Country (2021-2032) Figure 70. SAMEA Galectin 3 Sales Share by Country (2021-2032) Figure 71. Galectin 3 Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Galectin 3 Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • KTI
  • GRMD-03
  • GAL-300
  • ANG-4021
  • Others
Applications
  • Metastatic Melanoma
  • Portal Hypertension
  • Liver Cirrhosis
  • Others
Companies covered
  • MandalMed Inc
  • iTeos Therapeutics SA
  • GlycoMimetics Inc
  • Galectin Therapeutics Inc
  • Bristol-Myers Squibb Company
  • Angion Biomedica Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Galectin 3 Market by Type
  3. 1.2.1 Global Galectin 3 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 KTI
  5. 1.2.3 GRMD-03
  6. 1.2.4 GAL-300
  7. 1.2.5 ANG-4021
  8. 1.2.6 Others
  9. 1.3 Galectin 3 Market by Application
  10. 1.3.1 Global Galectin 3 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Metastatic Melanoma
  12. 1.3.3 Portal Hypertension
  13. 1.3.4 Liver Cirrhosis
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Galectin 3 Market Dynamics
  1. 2.1 Galectin 3 Industry Trends
  2. 2.2 Galectin 3 Industry Drivers
  3. 2.3 Galectin 3 Industry Opportunities and Challenges
  4. 2.4 Galectin 3 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Galectin 3 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Galectin 3 Revenue by Region
  3. 3.2.1 Global Galectin 3 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Galectin 3 Revenue by Region (2021-2026)
  5. 3.2.3 Global Galectin 3 Revenue by Region (2027-2032)
  6. 3.2.4 Global Galectin 3 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Galectin 3 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Galectin 3 Sales by Region
  9. 3.4.1 Global Galectin 3 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Galectin 3 Sales by Region (2021-2026)
  11. 3.4.3 Global Galectin 3 Sales by Region (2027-2032)
  12. 3.4.4 Global Galectin 3 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Galectin 3 Revenue by Manufacturers
  2. 4.1.1 Global Galectin 3 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Galectin 3 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Galectin 3 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Galectin 3 Sales by Manufacturers
  6. 4.2.1 Global Galectin 3 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Galectin 3 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Galectin 3 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Galectin 3 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Galectin 3 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Galectin 3 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Galectin 3 Manufacturers, Product Type & Application
  13. 4.7 Global Galectin 3 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Galectin 3 Market CR5 and HHI
  16. 4.8.2 2025 Galectin 3 Tier 1, Tier 2, and Tier 3
5 Galectin 3 Market by Type
  1. 5.1 Global Galectin 3 Revenue by Type
  2. 5.1.1 Global Galectin 3 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Galectin 3 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Galectin 3 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Galectin 3 Sales by Type
  6. 5.2.1 Global Galectin 3 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Galectin 3 Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Galectin 3 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Galectin 3 Price by Type
6 Galectin 3 Market by Application
  1. 6.1 Global Galectin 3 Revenue by Application
  2. 6.1.1 Global Galectin 3 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Galectin 3 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Galectin 3 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Galectin 3 Sales by Application
  6. 6.2.1 Global Galectin 3 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Galectin 3 Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Galectin 3 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Galectin 3 Price by Application
7 Company Profiles
  1. 7.1 MandalMed Inc
  2. 7.1.1 MandalMed Inc Company Information
  3. 7.1.2 MandalMed Inc Business Overview
  4. 7.1.3 MandalMed Inc Galectin 3 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 MandalMed Inc Galectin 3 Product Portfolio
  6. 7.1.5 MandalMed Inc Recent Developments
  7. 7.2 iTeos Therapeutics SA
  8. 7.2.1 iTeos Therapeutics SA Company Information
  9. 7.2.2 iTeos Therapeutics SA Business Overview
  10. 7.2.3 iTeos Therapeutics SA Galectin 3 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 iTeos Therapeutics SA Galectin 3 Product Portfolio
  12. 7.2.5 iTeos Therapeutics SA Recent Developments
  13. 7.3 GlycoMimetics Inc
  14. 7.3.1 GlycoMimetics Inc Company Information
  15. 7.3.2 GlycoMimetics Inc Business Overview
  16. 7.3.3 GlycoMimetics Inc Galectin 3 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlycoMimetics Inc Galectin 3 Product Portfolio
  18. 7.3.5 GlycoMimetics Inc Recent Developments
  19. 7.4 Galectin Therapeutics Inc
  20. 7.4.1 Galectin Therapeutics Inc Company Information
  21. 7.4.2 Galectin Therapeutics Inc Business Overview
  22. 7.4.3 Galectin Therapeutics Inc Galectin 3 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Galectin Therapeutics Inc Galectin 3 Product Portfolio
  24. 7.4.5 Galectin Therapeutics Inc Recent Developments
  25. 7.5 Bristol-Myers Squibb Company
  26. 7.5.1 Bristol-Myers Squibb Company Company Information
  27. 7.5.2 Bristol-Myers Squibb Company Business Overview
  28. 7.5.3 Bristol-Myers Squibb Company Galectin 3 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bristol-Myers Squibb Company Galectin 3 Product Portfolio
  30. 7.5.5 Bristol-Myers Squibb Company Recent Developments
  31. 7.6 Angion Biomedica Corp
  32. 7.6.1 Angion Biomedica Corp Company Information
  33. 7.6.2 Angion Biomedica Corp Business Overview
  34. 7.6.3 Angion Biomedica Corp Galectin 3 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Angion Biomedica Corp Galectin 3 Product Portfolio
  36. 7.6.5 Angion Biomedica Corp Recent Developments
8 North America
  1. 8.1 North America Galectin 3 Market Size by Type
  2. 8.1.1 North America Galectin 3 Revenue by Type (2021-2032)
  3. 8.1.2 North America Galectin 3 Sales by Type (2021-2032)
  4. 8.1.3 North America Galectin 3 Price by Type (2021-2032)
  5. 8.2 North America Galectin 3 Market Size by Application
  6. 8.2.1 North America Galectin 3 Revenue by Application (2021-2032)
  7. 8.2.2 North America Galectin 3 Sales by Application (2021-2032)
  8. 8.2.3 North America Galectin 3 Price by Application (2021-2032)
  9. 8.3 North America Galectin 3 Market Size by Country
  10. 8.3.1 North America Galectin 3 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Galectin 3 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Galectin 3 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Galectin 3 Market Size by Type
  2. 9.1.1 Europe Galectin 3 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Galectin 3 Sales by Type (2021-2032)
  4. 9.1.3 Europe Galectin 3 Price by Type (2021-2032)
  5. 9.2 Europe Galectin 3 Market Size by Application
  6. 9.2.1 Europe Galectin 3 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Galectin 3 Sales by Application (2021-2032)
  8. 9.2.3 Europe Galectin 3 Price by Application (2021-2032)
  9. 9.3 Europe Galectin 3 Market Size by Country
  10. 9.3.1 Europe Galectin 3 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Galectin 3 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Galectin 3 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Galectin 3 Market Size by Type
  2. 10.1.1 China Galectin 3 Revenue by Type (2021-2032)
  3. 10.1.2 China Galectin 3 Sales by Type (2021-2032)
  4. 10.1.3 China Galectin 3 Price by Type (2021-2032)
  5. 10.2 China Galectin 3 Market Size by Application
  6. 10.2.1 China Galectin 3 Revenue by Application (2021-2032)
  7. 10.2.2 China Galectin 3 Sales by Application (2021-2032)
  8. 10.2.3 China Galectin 3 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Galectin 3 Market Size by Type
  2. 11.1.1 Asia Galectin 3 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Galectin 3 Sales by Type (2021-2032)
  4. 11.1.3 Asia Galectin 3 Price by Type (2021-2032)
  5. 11.2 Asia Galectin 3 Market Size by Application
  6. 11.2.1 Asia Galectin 3 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Galectin 3 Sales by Application (2021-2032)
  8. 11.2.3 Asia Galectin 3 Price by Application (2021-2032)
  9. 11.3 Asia Galectin 3 Market Size by Country
  10. 11.3.1 Asia Galectin 3 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Galectin 3 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Galectin 3 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Galectin 3 Market Size by Type
  2. 12.1.1 SAMEA Galectin 3 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Galectin 3 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Galectin 3 Price by Type (2021-2032)
  5. 12.2 SAMEA Galectin 3 Market Size by Application
  6. 12.2.1 SAMEA Galectin 3 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Galectin 3 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Galectin 3 Price by Application (2021-2032)
  9. 12.3 SAMEA Galectin 3 Market Size by Country
  10. 12.3.1 SAMEA Galectin 3 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Galectin 3 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Galectin 3 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Galectin 3 Value Chain Analysis
  2. 13.1.1 Galectin 3 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Galectin 3 Production Mode & Process
  6. 13.2 Galectin 3 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Galectin 3 Distributors
  9. 13.2.3 Galectin 3 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst